Get a weekly summary of what Congress did, delivered every Sunday.

  • About
  • How Congress Works
  • Quiz
  • Congress Wrapped
  • Support Us
  • Roadmap
  • Health
  • Privacy Policy
  • Terms of Service
WhiteHouse.wiki•SCOTUS.wiki
Congress.wiki Alpha

This is not an official government website.

© 2026 PLEJ LC. All rights reserved.

Map
Live
Schedule
Daily Record
Special Rules
Subpoenas
Foreign Influence
Agencies
Regulations
Office Spending
US Code
Open search

Federal Regulations

How Congress's laws become real-world rules. Browse regulatory dockets from Regulations.gov — tracking rulemaking activity, public comment periods, and the agencies turning legislation into policy.

Dockets
6,106
Regulations.gov

Showing 30 of 6,106 dockets

Nonrulemaking
USDA

USDA-2026-0034

Request for Information on Opportunities, Challenges, and Emerging Areas in Statistical Data, Analysis, and Research at the U.S. Department of Agriculture

2 docs244 comments
Nonrulemaking
FDA

FDA-1995-P-0035

Use URAA to Determine Approval eff date of ANDA's

2 docs9 comments
Nonrulemaking
BOEM

BOEM-2025-0681

Notice of Intent to Prepare a Programmatic Environmental Impact Statement for Proposed Oil and Gas Lease Sales in the Northern, Central, and Southern California Program Areas

1 doc933 comments
Nonrulemaking
FDA

FDA-1995-P-0024

Refuse to Approve Any NDA for RU 486 Used as Abortifacient

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-1995-D-0288

Changes to Be Reported for Product & Establishment License Application; Guidance

39 docs16 comments
Comments due Mar 23, 2018
Nonrulemaking
FDA

FDA-2026-E-3826

Patent Term Extension Application for VOYXACT® (sibeprenlimab-szsi), Patent No. 10,385,123

2 docsNo comments
Nonrulemaking
NRC
Open for Comments

NRC-2026-0265

SMR, LLC Pioneer Units 1 and 2 Limited Work Authorization Application

2 docs1 comment
Comments due Apr 29, 2026
Nonrulemaking
FDA

FDA-1995-P-0373

Metered Dose N-acetylcysteine lysinate for Human Use via Oral Inhalation

15 docsNo comments
Nonrulemaking
FDA

FDA-2026-H-3607

DAB Civil Money Penalty; E.G.E. Corporation d/b/a Red Top Service Center

1 docNo comments
Nonrulemaking
FDA

FDA-2026-H-3604

DAB Civil Money Penalty; East Holly Oil, Inc. d/b/a Tubby’s / Mobil

1 docNo comments
Nonrulemaking
ONRR
Open for Comments

ONRR-2011-0006

OCS Net Profit Share Payment Reporting, 30 CFR Part 1220 -- 1012-0009 ICR

10 docs1 comment
Comments due Jun 9, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2026-N-0496

Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice Regulations For Medicated Feeds

1 doc1 comment
Comments due Apr 28, 2026
Nonrulemaking
FDA

FDA-2026-E-3828

Patent Term Extension Application for YARTEMLEA® (narsoplimab-wuug), Patent No. 9,011,860

2 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-3824

Patent Term Extension Application for NUZOLVENCE® (zoliflodacin), Patent No. 9,187,495

2 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-3822

Patent Term Extension Application for NEREUS® (tradipitant), Patent No. 12,318,375

2 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-3821

Patent Term Extension Application for NEREUS® (tradipitant), Patent No. 11,324,735

2 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-3820

Patent Term Extension Application for NEREUS® (tradipitant), Patent No. 10,821,099

2 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-3819

Patent Term Extension Application for NEREUS® (tradipitant), Patent No. 10,772,880

2 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-3818

Patent Term Extension Application for MYQORZO™ (aficamten), Patent No. 10,836,755

2 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-3817

Patent Term Extension Application for LEROCHOL® (lerodalcibep-liga), Patent No. 10,738,102

2 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-3816

Patent Term Extension Application for EXDENSUR® (depemokimab-ulaa), Patent No. 10,787,509

2 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-3815

Patent Term Extension Application for CARDAMYST™ (etripamil).Patent No. 10,117,848

3 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-3814

Patent Term Extension Application for CARDAMYST™ (etripamil).Patent No. 10,010,523

3 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-3813

Patent Term Extension Application for CARDAMYST™ (etripamil). Patent No. 10,010,522

3 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-3812

Patent Term Extension Application for CARDAMYST™ (etripamil), Patent No. 9,463,179

3 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-3811

Patent Term Extension Application for CARDAMYST™ (etripamil), Patent No. 9,227,918

3 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-3810

Patent Term Extension Application for Aptima® HPV Assay with the Panther® System, Patent No. 8,785,125

3 docsNo comments
Nonrulemaking
FDA

FDA-2026-H-3621

DAB Civil Money Penalty; Istrouma Market Inc. d/b/a EZ Stop

1 docNo comments
Rulemaking
IRS

IRS-2026-0299

Trump Accounts Contribution Pilot Program (REG-117002-25)

1 doc14 comments
Nonrulemaking
NASA
Open for Comments

NASA-2026-0067

Software Catalog

1 docNo comments
Comments due May 30, 2026
  • Previous
  • Page 65 of 204
  • Next